Churg-Strauss syndrome with severe granulomatous angiitis and crescentic glomerulonephritis, which developed during therapy with a leukotriene receptor antagonist

Clinical and Experimental Nephrology

Volumn 14, Issue 6, 2010, Pages 602-607

  Kanda, Takahiro ^a   Tanio, Hitoshi ^a   Wu, Chunmo ^a   Nishihara, Hiroji ^a   Nogaki, Fumiaki ^a   Ono, Takahiko ^a  

^a SHIMADA MUNICIPAL HOSPITAL   (Japan)

Author keywords

Angiitis; Churg Strauss syndrome; Giant cell; Granuloma; Leukotriene receptor antagonist

Indexed keywords

ALPHA 1 MICROGLOBULIN; C REACTIVE PROTEIN; CREATININE; FLUTICASONE; IMMUNOGLOBULIN E; MONTELUKAST; MYELOPEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; SALMETEROL;

AGED; ANEMIA; ARTICLE; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FEVER; GRANULOMATOUS VASCULITIS; HAND PARESTHESIA; HEMATURIA; HUMAN; KIDNEY BIOPSY; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; URINALYSIS;

ACETATES; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASTHMA; C-REACTIVE PROTEIN; CHURG-STRAUSS SYNDROME; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; PREDNISOLONE; QUINOLINES; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 78650941163     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0313-0     Document Type: Article

References (19)

1. ME Wechsler D Finn D Gunawardena R Westlake A Barker SP Haranath, et al. 2000 Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma Chest 117 708 713 1:CAS:528:DC%2BD3cXitlWmtLo%3D 10.1378/chest.117.3.708 10712995
2. PF Weller M Plaut V Taggart A Trontell 2006 The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report J Allergy Clin Immunol 117 1292 1302 10.1016/j.jaci.2006.02.042 16750989 (Pubitemid 43795762)
3. RL Green AG Vayonis 1999 Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment Lancet 353 725 726 1:STN:280:DyaK1M7ntFGgsw%3D%3D 10.1016/S0140-6736(99)00565-6 10073523 (Pubitemid 29103814)
4. IS Choi YI Koh JY Joo SH Lee WG Bae 2003 Churg Strauss syndrome may be induced by leukotriene modifiers in severe asthma Ann Allergy Asthma Immunol 91 98 10.1016/S1081-1206(10)62071-6 12877461
5. JG Lanham KB Elkon CD Pusey GR Hughes 1984 Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome Medicine (Baltimore) 63 65 81 1:STN:280:DyaL2c7ktFWqtA%3D%3D
6. J Churg L Strauss 1951 Allergic granulomatosis, allergic angiitis, and periarteritis nodosa Am J Pathol 27 277 301 1:STN:280:DyaG3M%2FkvVyisw%3D%3D 14819261
7. L Guillevin F Lhote M Gayraud P Cohen B Jarrousse O Lortholary, et al. 1996 Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome Medicine (Baltimore) 75 17 28 1:STN:280:DyaK287mtVentw%3D%3D 10.1097/00005792-199601000-00003 (Pubitemid 26041085)
8. C Pagnoux L Guillevin 2010 Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 22 21 28 10.1097/BOR.0b013e328333390b 19851111
9. RA Sinico L Di Toma U Maggiore P Bottero A Radice C Tosoni, et al. 2005 Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 2926 2935 1:CAS:528: DC%2BD2MXhtFeltrbO 10.1002/art.21250 16142760 (Pubitemid 41369124)
10. JM Drazen E Israel PM O'Byrne 1999 Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 197 206 1:STN:280: DyaK1M7gtFyltQ%3D%3D 10.1056/NEJM199901213400306 9895400 (Pubitemid 29063217)
11. 4 that mediates chemotaxis Nature 387 620 624 1:CAS:528:DyaK2sXktFCitb8%3D 10.1038/42506 9177352 (Pubitemid 27248768)
12. CG Löfdahl TF Reiss JA Leff E Israel MJ Noonan AF Finn, et al. 1999 Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients BMJ 319 87 90 10398629
13. AJ Mohammad LT Jacobsson KW Westman G Sturfelt M Segelmark 2009 Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa Rheumatology (Oxford) 48 1560 1565 10.1093/rheumatology/kep304
14. N Nathani MA Little H Kunst D Wilson DR Thickett 2008 Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective Thorax 63 883 888 1:STN:280:DC%2BD1cnivVGmtQ%3D%3D 10.1136/thx.2007.093955 18492740
15. S Bibby B Healy R Steele K Kumareswaran H Nelson R Beasley 2010 Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database Thorax 65 132 138 1:STN:280:DC%2BC3c%2FpvFWhtA%3D%3D 10.1136/thx.2009.120972 20147592
16. DL McDanel BA Muller 2005 The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction? Ther Clin Risk Manag 1 125 140 1:CAS:528:DC%2BD28Xhtlarsr3M 10.2147/tcrm.1.2.125.62913 18360552
17. R Sablé-Fourtassou P Cohen A Mahr C Pagnoux L Mouthon D Jayne, et al. 2005 Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome Ann Intern Med 143 632 638 16263885
18. K Suzuki S Kobayashi K Yamazaki M Gondo K Tomizawa Y Arimura, et al. 2007 Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population Microbiol Immunol 51 1215 1220 1:CAS:528: DC%2BD1cXhtlWjtbk%3D 18094540
19. B Hellmich E Csernok WL Gross 2005 Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome Ann N Y Acad Sci 1051 121 131 1:CAS:528:DC%2BD2MXhtFaktL7P 10.1196/annals.1361.053 16126951 (Pubitemid 41362739)